BRIEF: For the nine months ended 30 April 2008, Cantel Medical Corp.'s revenues increased 18% to $185.1M. Net income from continuing operations decreased 2% to $6.1M. Revenues reflect higher income from pre-existing business due to increased sales of endoscope reprocessing products & services. Net income was offset by higher selling expenses, increased general & administrative expenses, higher interest expenses and a decline in interest income.
Charles Diker, Chairman of the Board,
Andrew Krakauer, President,
Alan Hirschfield, Vice Chairman of the Board,
Craig Sheldon, Senior Vice President, Chief Financial Officer,
Roy Malkin, President, Chief Executive Officer of Minntech Corporation,
Gary Steinberg, Chief Executive Officer of Crosstex International, Inc.,
Mitchell Steinberg, President of Crosstex International, Inc.,
Curtis Weitnauer, President and CEO of Mar Cor Purification, Inc,
Eric Nodiff, Senior Vice President, General Counsel, Secretary,
Seth Segel, Senior Vice President - Corporate Development,
Steven Anaya, Vice President, Controller,
TRANSFER AGENT: American Stock Transfer and Trust.
Company reincorp. DE
Direct inquiries to: Director of Investor Relations
|
Cantel Medical Corp.
150 Clove Road
Little Falls, NJ 07424
Phone: 1-973-890-7220
Fax: 1-973-890-7270
Sector Name: Healthcare
Industry Name: Medical Equipment & Supplies
Employees: 843
Market Cap (Mil) $ : 154.664
Complete Financials: Apr 2008
Updated: 08/20/2008
Earnings
Announcements: N/A
|
| Key Ratios & Statistics |
| Price & Volume |
| Recent Price $ |
9.42 |
| 52 Week High $ |
20.91 |
| 52 Week Low $ |
8.85 |
| Avg Daily Vol (Mil) |
2.102 |
| Beta |
1.44 |
Share Related Items |
| Mkt. Cap. (Mil) $ |
154.664 |
| Shares Out (Mil) |
16.419 |
| Float (Mil) |
12.700 |
Dividend Information |
| Yield % |
N/A |
| Annual Dividend |
0.00 |
| Payout Ratio (TTM) % |
0.00 |
Financial Strength |
| Quick Ratio (MRQ) |
1.61 |
| Current Ratio (MRQ) |
2.55 |
| LT Debt/Equity (MRQ) |
33.76 |
| Total Debt/Equity (MRQ) |
38.26 |
|
|
| Valuation Ratios |
| Price/Earnings (TTM) |
19.26 |
| Price/Sales (TTM) |
.63 |
| Price/Book (MRQ) |
.92 |
| Price/Cash Flow (TTM) |
7.87 |
Per Share Data |
| Earnings (TTM) $ |
.49 |
| Sales (TTM) $ |
15.15 |
| Book Value (MRQ) $ |
10.24 |
| Cash Flow (TTM) $ |
1.20 |
| Cash (MRQ) $ |
1.19 |
Mgmt Efectiveness |
| Return on Equity (TTM) |
3.36 |
| Return on Assets (TTM) |
2.96 |
| Return on Investment (TTM) |
3.36 |
Profitability |
| Gross Margin (TTM) % |
34.77 |
| Operating Margin (TTM) % |
7.05 |
| Profit Margin (TTM) % |
3.23 |
|
|
Mil = Millions
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
Asterisks (*) indicates numbers are derived form Earnings Announcements
Pricing and volume data as of 08/20/2008 |
